Search form

Joseph Lazzarotti Discusses Implications of New FDA Approved Digital Pill

Joseph Lazzarotti discusses the first FDA approved drug with an embedded electronic sensor and concerns surrounding its security of patient data in "Amid Privacy Concerns, Medication Ushers In Brave New World of ‘Digital Medicine,’" published by the Health Care Compliance Association.






See AllRelated News

August 14, 2018
The Washington Post

Jason Gavejian Discusses Implications of Recording Conversations in the Workplace

August 14, 2018

Jason Gavejian discusses implications of secretly recording conversations in the workplace in  "Can you record your boss at work without him or her knowing?" published by The Washington Post. Subscription may be required to view article Read More

July 9, 2018

Jason Gavejian, Joseph Lazzarotti and Mary Costigan Discuss Successful Compliance With GDPR

July 9, 2018

Jason Gavejian, Joseph Lazzarotti and Mary Costigan discuss steps for businesses to take in the age of GDPR in "How the GDPR gives new meaning to established privacy and security principles," published by EVERFI. Subscription may be required to view article Read More

May 2, 2018
Bloomberg BNA Big Law Business

Joseph Lazzarotti Discusses the ‘Golden State Killer’ Case and Genetic Testing Companies’ Privacy Policies

May 2, 2018

Joseph Lazzarotti discusses privacy rights to genetic material turned over to third parties in "‘Golden State Killer’ Case Exposes Genetic Data Privacy Concerns," published by Bloomberg BNA Big Law Business. Subscription may be required to view article Read More